Drug intelligence / Profile preview

magnesium adenosine triphosphate

Development stage
Phase 2
Modality
Small Molecules
Administration
Intravenous
01

Overview

Magnesium adenosine triphosphate is a magnesium-coordinated ATP preparation, also described as ATP-magnesium or ATP-MgCl2. Mg-ATP is the physiologically relevant ATP complex that serves as a substrate and cofactor for ATP-dependent enzymes and cellular energy-dependent processes. When administered extracellularly in experimental settings, it can act as a purinergic agonist; in a murine polymicrobial-sepsis model, Mg-ATP activated macrophage P2X7 receptors and improved bacterial clearance, inflammation control, and survival. Historical preclinical and limited early clinical investigations evaluated intravenous ATP-MgCl2 for shock, ischemia, and ischemia-reperfusion injury, but it is not an identified approved pharmaceutical product or branded therapeutic program. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC4550379/))

Brand names
Atepodin
Other names
adenosine 5'-triphosphate magnesium saltadenosine triphosphate-magnesium chlorideATP magnesiumATP magnesium saltATP-MgCl2ATP-MgCl-2ATP-MgCl 2magnesium ATPmagnesium-adenosine triphosphateMg-ATP
02

Targets

P2RX7 (P2X purinoceptor 7)

Beyond the preview

Go deeper on magnesium adenosine triphosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on magnesium adenosine triphosphate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call